Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.

Genome medicine·2020
Same author

Aktuelle Urologie·2020
Same author

Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.

Urologic oncology·2020
Same author

Re: Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy Versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.

European urology·2020
Same author

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.

Clinical epigenetics·2020
Same author

Preservation of the bladder, but at what cost?

Translational andrology and urology·2020
Same journal

Profilin-1 as a Potential Biomarker in Acute Ischemic Stroke: Predictive Value for Large Vessel Occlusion and Mechanical Thrombectomy.

Clinical laboratory·2026
Same journal

Soluble Thrombomodulin can Predict In-Hospital Mortality of Community-Acquired Pneumonia Patients in Intensive Care Unit.

Clinical laboratory·2026
Same journal

Cytomegalovirus Seroprevalence in Morocco - a 10-Year Single-Center Study.

Clinical laboratory·2026
Same journal

Impact of Inactivated SARS-CoV-2 Vaccines on Serum Glycan Profiles and Protein N-Glycosylation.

Clinical laboratory·2026
Same journal

Albumin Concentration Associates Linearly with Unfavorable Outcomes at Three Months Post-Acute Ischemic Stroke in Koreans.

Clinical laboratory·2026
Same journal

Prognostic Value of the Blood Urea Nitrogen-to-Albumin Ratio for ICU Mortality in Cardiogenic Shock Patients: Evidence from the MIMIC-IV Database.

Clinical laboratory·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.0K

Age-Adapted Prostate Cancer Gene 3 Score Interpretation - Suggestions for Clinical Use.

Jörg Hennenlotter, Tim Neumann, Simon Alperowitz

    Clinical Laboratory
    |March 13, 2020
    PubMed
    Summary
    This summary is machine-generated.

    The prostate cancer antigen 3 (PCA3) gene score increases with age, requiring age-specific interpretation for accurate prostate cancer diagnosis. Adjusted cutoffs improve test performance across different age groups.

    More Related Videos

    A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
    06:08

    A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

    Published on: March 21, 2025

    960
    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    11.1K

    Related Experiment Videos

    Last Updated: Dec 26, 2025

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    17.0K
    A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
    06:08

    A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

    Published on: March 21, 2025

    960
    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    11.1K

    Area of Science:

    • Urology
    • Oncology
    • Biomarkers

    Background:

    • Prostate cancer antigen 3 (PCA3) urine assay aids biopsy decisions for suspected prostate cancer (PC).
    • Emerging evidence suggests PCA3 scores are influenced by patient age, impacting test interpretation.
    • Limited data exists on how specific age ranges affect PCA3 score interpretation.

    Purpose of the Study:

    • To re-evaluate the age dependency of the PCA3 score.
    • To provide age-specific interpretation guidelines for the PCA3 score in routine clinical practice.

    Main Methods:

    • Analyzed urine samples from 684 patients undergoing prostate biopsy or prostatectomy.
    • Assessed PCA3 scores and correlated them with patient age.
    • Divided patients into four age quartiles to determine age-specific cutoff values (≥60% specificity).

    Main Results:

    • PCA3 scores showed a significant correlation with patient age (p < 0.001).
    • Median PCA3 values and optimal cutoff values varied across age groups (<60, 60-65, 66-69, >69 years).
    • Age-adjusted interpretation improved overall test performance, including sensitivity and specificity.

    Conclusions:

    • PCA3 scores increase with age, necessitating age-specific reference values.
    • The standard cutoff of 35 is most suitable for patients in their sixties.
    • Lower (<60 years) and higher (>69 years) age groups require adjusted PCA3 cutoffs (20-30 and 40-50, respectively) for improved diagnostic accuracy.